176 related articles for article (PubMed ID: 22511903)
1. Analysis of prognostic factors and 5-year survival rate in patients with hepatocellular carcinoma: a single-center experience.
Lee SS; Shin HS; Kim HJ; Lee SJ; Lee HS; Hyun KH; Kim YH; Kwon BW; Han JH; Choi H; Kim BH; Lee JH; Kang HY; Shin HD; Song IH
Korean J Hepatol; 2012 Mar; 18(1):48-55. PubMed ID: 22511903
[TBL] [Abstract][Full Text] [Related]
2. Post-hepatectomy survival in advanced hepatocellular carcinoma with portal vein tumor thrombosis.
Yamamoto Y; Ikoma H; Morimura R; Shoda K; Konishi H; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Kubota T; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Sakakura C; Ochiai T; Otsuji E
World J Gastroenterol; 2015 Jan; 21(1):246-53. PubMed ID: 25574098
[TBL] [Abstract][Full Text] [Related]
3. Survival analysis of 904 patients with hepatocellular carcinoma in a hepatitis B virus-endemic area.
Park KW; Park JW; Choi JI; Kim TH; Kim SH; Park HS; Lee WJ; Park SJ; Hong EK; Kim CM
J Gastroenterol Hepatol; 2008 Mar; 23(3):467-73. PubMed ID: 17764529
[TBL] [Abstract][Full Text] [Related]
4. [Prognostic factors and model of primary liver cancer treated with transcatheter arterial chemoembolization combined with radiofrequency ablation].
Li J; Zhu WL; Kang XX; Zheng L; Guo CY; Yu P; Xiao JC
Zhonghua Zhong Liu Za Zhi; 2017 Oct; 39(10):787-791. PubMed ID: 29061025
[No Abstract] [Full Text] [Related]
5. Transarterial chemoembolization in unresectable hepatocellular carcinoma--assessing the factors affecting the survival: An audit from a tertiary care center in northern India.
Agarwal A; Yadav AK; Kumar A; Gupta S; Panwala HK; Redhu N; Hariprasad S; Ranjan P; Arora A; Gupta A
Indian J Gastroenterol; 2015 Mar; 34(2):117-26. PubMed ID: 25937484
[TBL] [Abstract][Full Text] [Related]
6. [Five-year survival analysis of a cohort of hepatocellular carcinoma patients who treated at the National Cancer Center, Korea].
Park KW; Park JW; Kim TH; Choi JI; Kim SH; Park HS; Park SJ; Lee WJ; Shin HL; Kim CM
Korean J Hepatol; 2007 Dec; 13(4):530-42. PubMed ID: 18159151
[TBL] [Abstract][Full Text] [Related]
7. Survival outcomes of hepatic resection compared with transarterial chemoembolization or sorafenib for hepatocellular carcinoma with portal vein tumor thrombosis.
Lee JM; Jang BK; Lee YJ; Choi WY; Choi SM; Chung WJ; Hwang JS; Kang KJ; Kim YH; Chauhan AK; Park SY; Tak WY; Kweon YO; Kim BS; Lee CH
Clin Mol Hepatol; 2016 Mar; 22(1):160-7. PubMed ID: 27044767
[TBL] [Abstract][Full Text] [Related]
8. AFP level and histologic differentiation predict the survival of patients with liver transplantation for hepatocellular carcinoma.
Yaprak O; Akyildiz M; Dayangac M; Demirbas BT; Guler N; Dogusoy GB; Yuzer Y; Tokat Y
Hepatobiliary Pancreat Dis Int; 2012 Jun; 11(3):256-61. PubMed ID: 22672818
[TBL] [Abstract][Full Text] [Related]
9. Modified cisplatin-based transcatheter arterial chemoembolization for large hepatocellular carcinoma: multivariate analysis of predictive factors for tumor response and survival in a 163-patient cohort.
Yoon HM; Kim JH; Kim EJ; Gwon DI; Ko GY; Ko HK
J Vasc Interv Radiol; 2013 Nov; 24(11):1639-46. PubMed ID: 23962438
[TBL] [Abstract][Full Text] [Related]
10. [Comparison of therapeutics effects of transcatheter arterial chemoembolization combined with iodine-125 seed implantation and sorafenib for the treatment of hepatocellular carcinoma with portal vein tumor thrombosis].
Luo J; Zheng JP; Shao GL; Wen S; Guo LW; Zeng H; Zhang L; Qian CY; Hao WY
Zhonghua Gan Zang Bing Za Zhi; 2018 Apr; 26(4):298-304. PubMed ID: 29996343
[No Abstract] [Full Text] [Related]
11. Favorable survival time provided with radioembolization in hepatocellular carcinoma patients with and without portal vein thrombosis.
Ozkan ZG; Poyanli A; Ucar A; Kuyumcu S; Akyuz F; Keskin S; Saglam S; Yilmaz E; Karaca C; Turkmen C
Cancer Biother Radiopharm; 2015 Apr; 30(3):132-8. PubMed ID: 25760644
[TBL] [Abstract][Full Text] [Related]
12. Growth velocity of the portal vein tumor thrombus accelerated by its progression, alpha-fetoprotein level, and liver fibrosis stage in patients with hepatocellular carcinoma.
Gon H; Kido M; Tanaka M; Kinoshita H; Komatsu S; Tsugawa D; Awazu M; Toyama H; Matsumoto I; Itoh T; Fukumoto T
Surgery; 2018 Nov; 164(5):1014-1022. PubMed ID: 30093272
[TBL] [Abstract][Full Text] [Related]
13. Histological differentiation predicts post-liver transplantation survival time.
Li WX; Li Z; Gao PJ; Gao J; Zhu JY
Clin Res Hepatol Gastroenterol; 2014 Apr; 38(2):201-8. PubMed ID: 24388339
[TBL] [Abstract][Full Text] [Related]
14. The prognosis of bulky hepatocellular carcinoma with nonmajor branch portal vein tumor thrombosis.
Jang TY; Huang CI; Yeh ML; Lin ZY; Chen SC; Chuang WL
Medicine (Baltimore); 2019 Mar; 98(13):e15066. PubMed ID: 30921239
[TBL] [Abstract][Full Text] [Related]
15. Prognostic index for portal vein tumor thrombosis in patients with hepatocellular carcinoma treated with radiation therapy.
Yu JI; Park HC; Lim DH; Park W; Yoo BC; Paik SW; Koh KC; Lee JH
J Korean Med Sci; 2011 Aug; 26(8):1014-22. PubMed ID: 21860551
[TBL] [Abstract][Full Text] [Related]
16. [Survival analysis for patients with hepatocellular carcinoma according to stage, liver function and treatment modalities].
Park KW; Park JW; Cho SH; Kim YI; Kim SH; Park HS; Lee WJ; Park SJ; Kim DY; Hong EK; Kim CM
Korean J Hepatol; 2006 Mar; 12(1):41-54. PubMed ID: 16565605
[TBL] [Abstract][Full Text] [Related]
17. Treatment outcome of transcatheter arterial chemoinfusion according to anticancer agents and prognostic factors in patients with advanced hepatocellular carcinoma (TNM stage IVa).
Ahn SH; Han KH; Park JY; Youn YH; Moon CM; Lee KS; Chon CY; Moon YM; Lee DY; Lee JT
Yonsei Med J; 2004 Oct; 45(5):847-58. PubMed ID: 15515195
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors for survival after transarterial chemoembolization combined with microwave ablation for hepatocellular carcinoma.
Ni JY; Sun HL; Chen YT; Luo JH; Chen D; Jiang XY; Xu LF
World J Gastroenterol; 2014 Dec; 20(46):17483-90. PubMed ID: 25516662
[TBL] [Abstract][Full Text] [Related]
19. Prediction of recurrence and prognosis in patients with hepatocellular carcinoma after resection by use of CLIP score.
Zhao WH; Ma ZM; Zhou XR; Feng YZ; Fang BS
World J Gastroenterol; 2002 Apr; 8(2):237-42. PubMed ID: 11925599
[TBL] [Abstract][Full Text] [Related]
20. Survival outcomes of hepatectomy for stage B Hepatocellular carcinoma in the BCLC classification.
Kamiyama T; Orimo T; Wakayama K; Shimada S; Nagatsu A; Yokoo H; Kamachi H; Yamashita K; Shimamura T; Taketomi A
World J Surg Oncol; 2017 Aug; 15(1):156. PubMed ID: 28830473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
